CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 4 Planned sale See Remarks sold 25,000 shares at $12.49 ($312,215)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale See Remarks sold 5,000 shares at $10.23 ($51,174)
- 4 Planned sale See Remarks sold 25,000 shares at $10.23 ($255,828)
- 4 Planned sale See Remarks sold 15,000 shares at $10.23 ($153,488)
- 4 Grant or award Director acquired 22,365 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Planned sale See Remarks sold 5,000 shares at $9.41 ($47,037)
- 4 Planned sale See Remarks sold 15,000 shares at $9.41 ($141,120)
- 4 Planned sale See Remarks sold 16,666 shares at $9.41 ($156,792)
- 144 Insider Sale of Securities
- 4 Planned sale See Remarks sold 25,000 shares at $10.00 ($250,000)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
Page 1 of 18 · 346 filings